MW
Mid-American Wealth Advisory Group, Inc.
13F filer · CIK 0001911264Reported Jul 16, 2026
Net buyer this quarter
13F portfolio value$277MU.S. long equity reported on 13F
Positions3013 new · 2 closed
Net flow last quarter+$40.2MBuys minus sells
Top 10 positions weight24.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 16, 202630 positions | |||||
| $45.5M | 16.45% | Not reported | New | Q2 2026 | |
| $4.02M | 1.45% | 0.00% | +582.5% | Q2 2024 | |
| OBONEZOne Bio, Corp. | $3.46M | 1.25% | Not reported | -18.9% | Q3 2025 |
| $3.35M | 1.21% | 0.00% | -27.8% | Q3 2023 | |
| $3.02M | 1.09% | 0.00% | -19.9% | Q1 2022 | |
| $2.33M | 0.84% | 0.00% | +0.3% | Q4 2025 | |
| $1.31M | 0.47% | 0.00% | -30.7% | Q1 2022 | |
| $1.26M | 0.45% | 0.00% | -33.7% | Q1 2022 | |
| $1.25M | 0.45% | 0.00% | +34.4% | Q1 2022 | |
| $1.01M | 0.37% | 0.00% | +123.8% | Q1 2022 | |
| $818K | 0.30% | 0.00% | +133.4% | Q1 2022 | |
| $809K | 0.29% | 0.00% | +123.2% | Q4 2024 | |
| $792K | 0.29% | 0.00% | +5.1% | Q2 2023 | |
| $723K | 0.26% | Not reported | +112.9% | Q1 2025 | |
| $623K | 0.23% | 0.00% | New | Q2 2026 | |
| $590K | 0.21% | 0.00% | -7.3% | Q1 2022 | |
| $481K | 0.17% | Not reported | Not reported | Q2 2025 | |
| $435K | 0.16% | 0.00% | Not reported | Q2 2025 | |
| $430K | 0.16% | 0.00% | +4.1% | Q1 2022 | |
| $414K | 0.15% | 0.27% | New | Q2 2026 | |
| $401K | 0.14% | Not reported | Not reported | Q2 2024 | |
| $392K | 0.14% | 0.00% | New | Q2 2026 | |
| $390K | 0.14% | 0.00% | New | Q2 2026 | |
| $378K | 0.14% | 0.00% | Not reported | Q2 2025 | |
| $368K | 0.13% | 0.00% | Not reported | Q2 2025 | |
| $307K | 0.11% | 0.00% | -3.6% | Q1 2022 | |
| $297K | 0.11% | 0.00% | New | Q2 2026 | |
| $246K | 0.09% | 0.00% | Not reported | Q2 2025 | |
| $214K | 0.08% | 0.00% | Not reported | Q1 2022 | |
| $204K | 0.07% | 0.00% | -96.8% | Q1 2022 | |
| Q1 2026Reported Apr 23, 202619 positions | |||||
| $4.69M | 1.98% | Not reported | Not reported | Q4 2024 | |
| $4.35M | 1.84% | 0.00% | Not reported | Q3 2023 | |
| $4.16M | 1.76% | 0.00% | Not reported | Q1 2022 | |
| OBONEZOne Bio, Corp. | $4.02M | 1.70% | Not reported | Not reported | Q3 2025 |
| $3.63M | 1.53% | 0.00% | Not reported | Q1 2022 | |
| $2.3M | 0.97% | 0.00% | Not reported | Q4 2025 | |
| $1.63M | 0.69% | 0.00% | Not reported | Q1 2022 | |
| $1.51M | 0.64% | 0.00% | Not reported | Q1 2022 | |
| $874K | 0.37% | 0.00% | Not reported | Q1 2022 | |
| $685K | 0.29% | 0.00% | Not reported | Q1 2022 | |
| $665K | 0.28% | 0.18% | Not reported | Q3 2025 | |
| $660K | 0.28% | 0.00% | Not reported | Q2 2023 | |
| $548K | 0.23% | 0.00% | Not reported | Q2 2024 | |
| $454K | 0.19% | 0.00% | Not reported | Q1 2022 | |
| $438K | 0.18% | 0.00% | Not reported | Q1 2022 | |
| $406K | 0.17% | 0.00% | Not reported | Q1 2022 | |
| $387K | 0.16% | 0.00% | Not reported | Q4 2024 | |
| $342K | 0.14% | 0.00% | Not reported | Q1 2022 | |
| $302K | 0.13% | Not reported | Not reported | Q1 2025 | |
| Q4 2025Reported Jan 23, 202619 positions | |||||
| $4.69M | 1.98% | Not reported | +7.9% | Q4 2024 | |
| $4.35M | 1.84% | 0.00% | +6.9% | Q3 2023 | |
| $4.16M | 1.76% | 0.00% | -2.6% | Q1 2022 | |
| OBONEZOne Bio, Corp. | $4.02M | 1.70% | Not reported | -3.0% | Q3 2025 |
| $3.63M | 1.53% | 0.00% | +4.0% | Q1 2022 | |
| $2.3M | 0.97% | 0.00% | New | Q4 2025 | |
| $1.63M | 0.69% | 0.00% | +0.9% | Q1 2022 | |
| $1.51M | 0.64% | 0.00% | -7.8% | Q1 2022 | |
| $874K | 0.37% | 0.00% | +18.1% | Q1 2022 | |
| $685K | 0.29% | 0.00% | -3.6% | Q1 2022 | |
| $665K | 0.28% | 0.17% | +82.5% | Q3 2025 | |
| $660K | 0.28% | 0.00% | +86.6% | Q2 2023 | |
| $548K | 0.23% | 0.00% | +16.7% | Q2 2024 | |
| $454K | 0.19% | 0.00% | +28.1% | Q1 2022 | |
| $438K | 0.18% | 0.00% | +10.6% | Q1 2022 | |
| $406K | 0.17% | 0.00% | +10.9% | Q1 2022 | |
| $387K | 0.16% | 0.00% | -12.2% | Q4 2024 | |
| $342K | 0.14% | 0.00% | -1.9% | Q1 2022 | |
| $302K | 0.13% | Not reported | Not reported | Q1 2025 | |
| Q3 2025Reported Oct 20, 202517 positions | |||||
| $4.41M | 1.97% | Not reported | +15.7% | Q4 2024 | |
| OBONEZOne Bio, Corp. | $4.23M | 1.89% | Not reported | New | Q3 2025 |
| $3.79M | 1.69% | 0.00% | -4.3% | Q1 2022 | |
| $3.76M | 1.68% | 0.00% | +0.3% | Q1 2022 | |
| $3.4M | 1.52% | 0.00% | +2.6% | Q3 2023 | |
| $1.88M | 0.84% | 0.00% | -3.8% | Q1 2022 | |
| $1.53M | 0.69% | 0.00% | -2.2% | Q1 2022 | |
| $693K | 0.31% | 0.00% | -42.1% | Q1 2022 | |
| $637K | 0.28% | 0.00% | -4.0% | Q1 2022 | |
| $470K | 0.21% | 0.00% | -59.1% | Q2 2024 | |
| $436K | 0.19% | 0.00% | -51.0% | Q4 2024 | |
| $380K | 0.17% | 0.00% | -59.3% | Q1 2022 | |
| $377K | 0.17% | 0.00% | -57.7% | Q1 2022 | |
| $367K | 0.16% | 0.09% | New | Q3 2025 | |
| $339K | 0.15% | 0.00% | -0.2% | Q1 2022 | |
| $313K | 0.14% | 0.00% | -4.4% | Q1 2022 | |
| $275K | 0.12% | 0.00% | -10.0% | Q2 2023 | |
Premium opens every quarter this fund has filed